Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.
PredictImmune has raised €11M across 1 funding round from 2 investors, most recently a Series B round in Jul 2019. Based in Cambridge, UK; founded 2017; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-07-01 | Series B |
| €11M |
| Parkwalk Advisors,University of Cambridge Enterprise |
| View deal → |
